Статья
Возможности магнитно-резонансной томографии в диагностике легочной артериальной гипертензии
Появление все более эффективных методов терапии легочной артериальной гипертензии (ЛАГ) повысило необходимость в надежных неинвазивных методах диагностики, мониторинга течения заболевания и ответа на лечение. Появляется все больше данных об актуальности использования магнитно-резонансной томографии (МРТ) для обследования пациентов с ЛАГ. В обзоре приведены данные исследований, показывающие значение МРТ для неинвазивной оценки структуры и функции сердца у пациентов с ЛАГ, а также для оценки ремоделирования легочного сосудистого русла и визуализации легочного кровотока. Согласно результатам исследований, представленных в обзоре, данные, полученные с помощью различных современных технологий МРТ, могут быть использованы для отслеживания эффекта терапии и проведения стратификации риска у пациентов с ЛАГ.
1. Чазова И. Е., Мартынюк Т.В., Валиева З.С., Азизов В.А., Барбараш О.Л., Веселова Т.Н. и др. Евразийские клинические рекомендации по диагностике и лечению легочной гипертензии. Евразийский кардиологический журнал. 2020;1(30):78-122. DOI: 10.24411/2076-4766-2020-10002
2. Чазова И. Е., Яровой С.Ю., Данилов Н. М. Эволюция патогенетической терапии легочной артериальной гипертензии. Терапевтический архив. 2019;91(12):4-9. DOI: 10.26442/00403660.2019.12.000475
3. Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A et al. Diagnosis of pulmonary hypertension. European Respiratory Journal. 2019;53(1):1801904. DOI: 10.1183/13993003.01904-2018
4. Vonk Noordegraaf A, Galie N. The role of the right ventricle in pulmonary arterial hypertension. European Respiratory Review. 2011;20(122):243–53. DOI: 10.1183/09059180.00006511
5. Baggen VJM, Leiner T, Post MC, van Dijk AP, Roos-Hesselink JW, Boersma E et al. Cardiac magnetic resonance findings predicting mortality in patients with pulmonary arterial hypertension: a systematic review and meta-analysis. European Radiology. 2016;26(11):3771–80. DOI: 10.1007/s00330-016-4217-6
6. Peacock AJ, Crawley S, McLure L, Blyth KG, Vizza CD, Poscia R et al. Changes in Right Ventricular Function Measured by Cardiac Magnetic Resonance Imaging in Patients Receiving Pulmonary Arterial Hypertension–Targeted Therapy: The EURO-MR Study. Circulation: Cardiovascular Imaging. 2014;7(1):107–14. DOI: 10.1161/CIRCIMAGING.113.000629
7. Swift AJ, Capener D, Johns C, Hamilton N, Rothman A, Elliot C et al. Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 2017;196(2):228–39. DOI: 10.1164/rccm.201611-2365OC
8. Lewis RA, Johns CS, Cogliano M, Capener D, Tubman E, Elliot CA et al. Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 2020;201(4):458–68. DOI: 10.1164/rccm.201909-1771OC
9. Noordegraaf AV, Channick R, Cottreel E, Kiely D, Martin N, Moiseeva O et al. Results from the REPAIR Study Final Analysis: Effects ofMacitentan on Right Ventricular (RV) Remodelling in Pulmonary Arterial Hypertension (PAH). The Journal of Heart and Lung Transplantation. 2020;39(4):S16–7. DOI: 10.1016/j.healun.2020.01.1140
10. Swift A, Cogliano M, Oram C, Kendall L, Capener D, Garg P et al. Repeatability and Sensitivity to change of right ventricular analysis methods using cardiac magnetic resonance imaging in PAH: results from the RESPIRE Study. European Respiratory Journal. 2019;54(Suppl 63):PA3164Av. at: http://erj.ersjournals.com/lookup/doi/10.1183/13993003.congress-2019.PA3164.
11. Swift AJ, Rajaram S, Condliffe R, Capener D, Hurdman J, Elliot CA et al. Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry. Journal of Cardiovascular Magnetic Resonance. 2012;14(1):40. DOI: 10.1186/1532-429X-14-40
12. Hagger D, Condliffe R, Woodhouse N, Elliot CA, Armstrong IJ, Davies C et al. Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology. 2009;48(9):1137–42. DOI: 10.1093/rheumatology/kep187
13. Белевская А.А., Дадачева З.Х., Саидова М.А, Мартынюк Т.В., Чазова И.Е. Возможности эхокардиографии в диагностике легочной гипертензии и оценке ремоделирования сердца. Лечебное дело. 2015;1:111-21
14. Beyar R, Dong SJ, Smith ER, Belenkie I, Tyberg JV. Ventricular interaction and septal deformation: a model compared with experimental data. American Journal of Physiology-Heart and Circulatory Physiology. 1993;265(6):H2044–56. DOI: 10.1152/ajpheart.1993.265.6.H2044
15. Dellegrottaglie S, Sanz J, Poon M, Viles-Gonzalez JF, Sulica R, Goyenechea M et al. Pulmonary Hypertension: Accuracy of Detection with Left Ventricular Septal-to–Free Wall Curvature Ratio Measured at Cardiac MR. Radiology. 2007;243(1):63–9. DOI: 10.1148/radiol.2431060067
16. Swift A, Rajaram S, Condliffe R, Marshall H, Capener D, Hurdman J et al. Mean eccentricity index strongly reflects mPAP in patients with IPAH using CINE cardiac MRI. European Respiratory Journal. 2011;38(Suppl 55):1442.
17. Yamasaki Y, Nagao M, Kamitani T, Yamanouchi T, Kawanami S, Yamamura K et al. Clinical impact of left ventricular eccentricity index using cardiac MRI in assessment of right ventricular hemodynamics and myocardial fibrosis in congenital heart disease. European Radiology. 2016;26(10):3617–25. DOI: 10.1007/s00330-015-4199-9
18. Терновой С.К. Томография сердца. - М: ГЭОТАР-Медиа, 2018. - 296с. ISBN 978-5-9704-4608-9
19. Freed BH, Gomberg-Maitland M, Chandra S, Mor-Avi V, Rich S, Archer SL et al. Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. Journal of Cardiovascular Magnetic Resonance. 2012;14(1):11. DOI: 10.1186/1532-429X-14-11
20. Bessa LGP, Junqueira FP, Bandeira ML da S, Garcia MI, Xavier SS, Lavall G et al. Pulmonary Arterial Hypertension: Use of Delayed Contrast-Enhanced Cardiovascular Magnetic Resonance in Risk Assessment. Arquivos Brasileiros de Cardiologia. 2013;101(4):336–45. DOI: 10.5935/abc.20130168
21. Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). Journal of Cardiovascular Magnetic Resonance. 2017;19(1):75. DOI: 10.1186/s12968-017-0389-8
22. Reiter U, Reiter G, Kovacs G, Adelsmayr G, Greiser A, Olschewski H et al. Native myocardial T1 mapping in pulmonary hypertension: correlations with cardiac function and hemodynamics. European Radiology. 2017;27(1):157–66. DOI: 10.1007/s00330-016-4360-0
23. Saunders LC, Johns CS, Stewart NJ, Oram CJE, Capener DA, Puntmann VO et al. Diagnostic and prognostic significance of cardiovascular magnetic resonance native myocardial T1 mapping in patients with pulmonary hypertension. Journal of Cardiovascular Magnetic Resonance. 2018;20(1):78. DOI: 10.1186/s12968-018-0501-8
24. de Siqueira MEM, Pozo E, Fernandes VR, Sengupta PP, Modesto K, Gupta SS et al. Characterization and clinical significance of right ventricular mechanics in pulmonary hypertension evaluated with cardiovascular magnetic resonance feature tracking. Journal of Cardiovascular Magnetic Resonance. 2016;18(1):39. DOI: 10.1186/s12968-016-0258-x
25. Padervinskienė L, Krivickienė A, Hoppenot D, Miliauskas S, Basevičius A, Nedzelskienė I et al. Prognostic Value of Left Ventricular Function and Mechanics in Pulmonary Hypertension: A Pilot Cardiovascular Magnetic Resonance Feature Tracking Study. Medicina. 2019;55(3):73. DOI: 10.3390/medicina55030073
26. Reiter U, Reiter G, Fuchsjäger M. MR phase-contrast imaging in pulmonary hypertension. The British Journal of Radiology. 2016;89(1063):20150995. DOI: 10.1259/bjr.20150995
27. Reiter G, Reiter U, Kovacs G, Olschewski H, Fuchsjäger M. Blood Flow Vortices along the Main Pulmonary Artery Measured with MR Imaging for Diagnosis of Pulmonary Hypertension. Radiology. 2015;275(1):71–9. DOI: 10.1148/radiol.14140849
28. Helderman F, Mauritz G-J, Andringa KE, Vonk-Noordegraaf A, Marcus JT. Early onset of retrograde flow in the main pulmonary artery is a characteristic of pulmonary arterial hypertension. Journal of Magnetic Resonance Imaging. 2011;33(6):1362–8. DOI: 10.1002/jmri.22581
29. Nogami M, Ohno Y, Koyama H, Kono A, Takenaka D, Kataoka T et al. Utility of phase contrast MR imaging for assessment of pulmonary flow and pressure estimation in patients with pulmonary hypertension: Comparison with right heart catheterization and echocardiography. Journal of Magnetic Resonance Imaging. 2009;30(5):973–80. DOI: 10.1002/jmri.21935
30. Garcia-Alvarez A, Fernandez-Friera L, Mirelis JG, Sawit S, Nair A, Kallman J et al. Non-invasive estimation of pulmonary vascular resistance with cardiac magnetic resonance. European Heart Journal. 2011;32(19):2438–45. DOI: 10.1093/eurheartj/ehr173
31. Sanz J, Kariisa M, Dellegrottaglie S, Prat-González S, Garcia MJ, Fuster V et al. Evaluation of Pulmonary Artery Stiffness in Pulmonary Hypertension With Cardiac Magnetic Resonance. JACC: Cardiovascular Imaging. 2009;2(3):286–95. DOI: 10.1016/j.jcmg.2008.08.007
32. Tan W, Madhavan K, Hunter KS, Park D, Stenmark KR. Vascular Stiffening in Pulmonary Hypertension: Cause or Consequence? Pulmonary Circulation. 2014;4(4):560–80. DOI: 10.1086/677370
33. Ray JC, Burger C, Mergo P, Safford R, Blackshear J, Austin C et al. Pulmonary arterial stiffness assessed by cardiovascular magnetic resonance imaging is a predictor of mild pulmonary arterial hypertension. The International Journal of Cardiovascular Imaging. 2019;35(10):1881–92. DOI: 10.1007/s10554-018-1397-y